Celprogen Introduces Non-Viral Method to Reprogram Adult Somatic Cells (De-differentiation) to Their Embryonic Pluripotent Cells (iPCs)

SAN PEDRO, Calif.--Celprogen Inc. has announced that they have successfully De-DIFFERENTIATED Human Somatic Cells (primary skin fibroblast, keratinocytes, cardiac, liver and neuronal cells) to their embryonic like pluripotent cells (iPCs). This De-differentiation process was achieved with non-viral induction utilizing Celprogen’s De-differentiation media and matrix system for reprogramming adult somatic cells to iPCs in tissue culture. [...]

Varian, Inc. Announces Online Experience

PALO ALTO, Calif., Jan. 12 -- Varian, Inc. (NasdaqGS: VARI - News) has announced that it will host a unique online event involving the breadth and depth of its solutions for analytical and research applications as an alternative to participating as a booth exhibitor at Pittcon®2009. Varian recognizes the growing trend toward gathering information online. [...]

Singulex Closes $19 Million Financing Round

ALAMEDA, Calif., Jan. 12 -- Singulex, Inc. today announced that it has closed a $19 million financing round, led by JAFCO Co., Ltd. and supported by existing investors including OrbiMed Advisors and Fisk Ventures. The financing round will support the commercialization of Singulex technologies in the diagnostics market. As part of the financing, Hironori Hozoji, [...]

Waters Introduces the Xevo QTof MS and Once Again Redefines Mass Spectrometry

Industry's Most Sensitive Benchtop QTof Mass Spectrometry System Accelerates Today's Laboratory Workflow with Unrivaled Performance and Simplicity MILFORD, Mass., Jan. 12 -- Waters Corporation (NYSE: WAT - News) today introduced its Waters® Xevo(TM) quadrupole time-of-flight (QTof) mass spectrometer (MS), an exact mass MS/MS benchtop instrument that is the most sensitive benchtop QTof system ever. Aimed [...]

EU Launches Project to Improve In-Vitro Diagnostics

VENLO, THE NETHERLANDS--Jan 12, 2009 -- QIAGEN led-consortium to develop standards for patient sample processing in order to facilitate the discovery and prediction of diseases Venlo, The Netherlands, January 12, 2009 - The European Union launched a new research project targeting to expand the potentials and utility of in-vitro diagnostics through the creation of new [...]

Bruker AXS Introduces the M1 MISTRAL(TM) Gold and Jewelry Analyzer at ARABLAB 2009DUBAI

United Arab Emirates Jan 11, 2009 -- At ARABLAB 2009, Bruker AXS is introducing the M1 MISTRAL(TM), a compact table-top microanalysis X-ray fluorescence (XRF) spectrometer, which was developed specifically for non-destructive analysis of gold and other precious metals. The system provides fast and accurate results on the elemental composition of metals and alloys used for [...]

CSC Scientific Announces Addition of NIR On-line Moisture Capability

CSC Scientific Company partners with Moisture Register to add On-line NIR to its wide selection of moisture test equipment. This puts CSC Scientific in a position to provide a complete range of moisture analysis solutions. Fairfax, Virginia (PRWEB) January 10, 2009 -- CSC Scientific Company, Inc. announces a new affiliation with Moisture Register, a division [...]

Restek Announces Transition to 100% Employee Ownership and Creation of SilcoTek

Restek Corporation announced their anticipated January 1, 2009 transition from 22% to 100% employee ownership under an ESOP structure. Restek has been planning for and testing employee ownership models since its inception in 1985. Don McCandless will continue to lead the company as Head Coach. Founder Paul Silvis will remain as Chairman of the Board [...]

AnaSpec Introduces New ClearPoint™ beta-Amyloid Peptides

San Jose, CA, United States, 01/09/2009 - ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled peptides and amino acids. AnaSpec has announced the release of its newest collection of ClearPoint™ b-Amyloid peptides. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled peptides and amino acids. These peptides can [...]

Roche NimbleGen partners with Biogemma on the development of Sequence Capture technology for targeted high-throughput sequencing of crop genomes

Madison, 09.01.2009, Roche NimbleGen and Biogemma entered into a research agreement which will apply Roche NimbleGen's array-based Sequence Capture complexity reduction technology to provide targeted re-sequencing of crop plant genomes. The goal of this partnership is to develop new technologies that enable large-scale genomic marker discovery in plants, which will greatly facilitate marker-assisted breeding programs [...]

Access IBO on Knowledge Center